{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,25]],"date-time":"2026-03-25T03:53:00Z","timestamp":1774410780653,"version":"3.50.1"},"reference-count":33,"publisher":"Impact Journals, LLC","issue":"18","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Oncotarget"],"published-print":{"date-parts":[[2017,5,2]]},"DOI":"10.18632\/oncotarget.15426","type":"journal-article","created":{"date-parts":[[2017,2,22]],"date-time":"2017-02-22T16:33:37Z","timestamp":1487781217000},"page":"30511-30523","source":"Crossref","is-referenced-by-count":25,"title":["Serious adverse events of cell therapy for respiratory diseases: a systematic review and meta-analysis"],"prefix":"10.18632","volume":"8","author":[{"given":"Runzhen","family":"Zhao","sequence":"first","affiliation":[{"name":"Texas Lung Injury Institute, University of Texas Health Northeast, Tyler, Texas, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhenlei","family":"Su","sequence":"additional","affiliation":[{"name":"Institute of Lung and Molecular Therapy, Xinxiang Medical University, Xinxiang, Henan, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jing","family":"Wu","sequence":"additional","affiliation":[{"name":"Institute of Lung and Molecular Therapy, Xinxiang Medical University, Xinxiang, Henan, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hong-Long","family":"Ji","sequence":"additional","affiliation":[{"name":"Texas Lung Injury Institute, University of Texas Health Northeast, Tyler, Texas, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"7892","published-online":{"date-parts":[[2017,2,16]]},"reference":[{"key":"1","doi-asserted-by":"publisher","first-page":"788","DOI":"10.1001\/jama.2016.0291","article-title":"Epidemiology, Patterns of Care, and Mortality for Patients With Acute Respiratory Distress Syndrome in Intensive Care Units in 50 Countries","volume":"315","author":"Thompson","year":"2016","journal-title":"JAMA"},{"key":"2","doi-asserted-by":"publisher","first-page":"1016","DOI":"10.1016\/S2213-2600(14)70217-6","article-title":"Mesenchymal stem cells: mechanisms of potential therapeutic benefit in ARDS and sepsis","volume":"2","author":"Matthay","year":"2014","journal-title":"Lancet Respir Med"},{"key":"3","doi-asserted-by":"publisher","first-page":"e0147170","DOI":"10.1371\/journal.pone.0147170","article-title":"Efficacy of mesenchymal stromal cell therapy for acute lung injury in preclinical animal models: a systematic review","volume":"11","author":"Rudnicki","year":"2016","journal-title":"PLoS One"},{"key":"4","doi-asserted-by":"publisher","first-page":"e0157099","DOI":"10.1371\/journal.pone.0157099","article-title":"Preclinical Studies of Mesenchymal Stem Cell (MSC) Administration in Chronic Obstructive Pulmonary Disease (COPD): A Systematic Review and Meta-Analysis","volume":"11","author":"Kim","year":"2016","journal-title":"PLoS One"},{"key":"5","doi-asserted-by":"publisher","first-page":"1437","DOI":"10.1002\/stem.2357","article-title":"Concise Review: the bystander effect: mesenchymal stem cell-mediated lung repair","volume":"34","author":"Westergren-Thorsson","year":"2016","journal-title":"Stem Cells"},{"key":"6","doi-asserted-by":"publisher","first-page":"509","DOI":"10.3346\/jkms.2015.30.5.509","article-title":"Stem cell therapy for bronchopulmonary dysplasia: bench to bedside translation","volume":"30","author":"Park","year":"2015","journal-title":"J Korean Med Sci"},{"key":"7","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1097\/MCC.0000000000000276","article-title":"Stem cell therapy for acute respiratory distress syndrome: a promising future?","volume":"22","author":"Laffey","year":"2016","journal-title":"Curr Opin Crit Care"},{"key":"8","doi-asserted-by":"publisher","first-page":"965","DOI":"10.1378\/chest.10-0518","article-title":"Therapeutic potential of mesenchymal stem cells for severe acute lung injury","volume":"138","author":"Lee","year":"2010","journal-title":"Chest"},{"key":"9","doi-asserted-by":"publisher","first-page":"1590","DOI":"10.1378\/chest.12-2094","article-title":"A placebo-controlled, randomized trial of mesenchymal stem cells in COPD","volume":"143","author":"Tashkin","year":"2013","journal-title":"Chest"},{"key":"10","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1186\/1465-9921-15-39","article-title":"Treatment of acute respiratory distress syndrome with allogeneic adipose-derived mesenchymal stem cells: a randomized, placebo-controlled pilot study","volume":"15","author":"Xu","year":"2014","journal-title":"Respir Res"},{"key":"11","first-page":"811","article-title":"Effects of human umbilical cord mesenchymal stem cells in the treatment of paraquat-induced lung injury. [Article in Chinese]","volume":"30","author":"Zhong","year":"2012","journal-title":"Chin J Ind Hyg Occup Dis"},{"key":"12","doi-asserted-by":"publisher","first-page":"966","DOI":"10.1016\/j.jpeds.2013.12.011","article-title":"Mesenchymal stem cells for bronchopulmonary dysplasia: phase 1 dose-escalation clinical trial","volume":"164","author":"Park","year":"2014","journal-title":"J Pediatr"},{"key":"13","doi-asserted-by":"publisher","first-page":"1566","DOI":"10.1016\/j.jacc.2006.12.037","article-title":"Transplantation of autologous endothelial progenitor cells may be beneficial in patients with idiopathic pulmonary arterial hypertension: a pilot randomized controlled trial","volume":"49","author":"Chen","year":"2007","journal-title":"J Am Coll Cardiol"},{"key":"14","first-page":"563","article-title":"Clinical Evaluation of the Safety and Feasibility of Whole Autologous Cord Blood Transplant as a Source of Stem and Progenitor Cells for Extremely Premature Neonates: Preliminary Report","volume":"13","author":"Machalinski","year":"2015","journal-title":"Exp Clin Transplant"},{"key":"15","doi-asserted-by":"publisher","first-page":"63","DOI":"10.2147\/COPD.S15292","article-title":"Unicentric study of cell therapy in chronic obstructive pulmonary disease\/pulmonary emphysema","volume":"6","author":"Lago","year":"2011","journal-title":"Int J Chron Obstruct Pulmon Dis"},{"key":"16","doi-asserted-by":"publisher","first-page":"352","DOI":"10.5581\/1516-8484.20130113","article-title":"Phase I clinical trial of cell therapy in patients with advanced chronic obstructive pulmonary disease: follow-up of up to 3 years","volume":"35","author":"Ribeiro-Paes","year":"2013","journal-title":"Rev Bras Hematol Hemoter"},{"key":"17","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1093\/qjmed\/hcw001","article-title":"A phase I study for intravenous autologous mesenchymal stromal cell administration to patients with severe emphysema","volume":"109","author":"Hiemstra","year":"2016","journal-title":"QJM"},{"key":"18","doi-asserted-by":"publisher","first-page":"650","DOI":"10.1111\/j.1399-3046.2007.00863.x","article-title":"Safety and efficacy of autologous endothelial progenitor cells transplantation in children with idiopathic pulmonary arterial hypertension: open-label pilot study","volume":"12","author":"Chen","year":"2008","journal-title":"Pediatr Transplant"},{"key":"19","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1007\/s10517-009-0538-7","article-title":"Possibilities for the use of autologous mesenchymal stem cells in the therapy of radiation-induced lung injuries","volume":"147","author":"Konoplyannikova","year":"2009","journal-title":"Bull Exp Biol Med"},{"key":"20","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1016\/S2213-2600(14)70291-7","article-title":"Mesenchymal stem (stromal) cells for treatment of ARDS: a phase 1 clinical trial","volume":"3","author":"Wiener-Kronish","year":"2015","journal-title":"Lancet Respir Med"},{"key":"21","doi-asserted-by":"publisher","first-page":"645","DOI":"10.1161\/CIRCRESAHA.114.305951","article-title":"Endothelial NO-Synthase Gene-Enhanced Progenitor Cell Therapy for Pulmonary Arterial Hypertension: The PHACeT","volume":"117","author":"Stewart","year":"2015","journal-title":"Trial. Circ Res"},{"key":"22","doi-asserted-by":"publisher","first-page":"438","DOI":"10.3346\/jkms.2014.29.3.438","article-title":"Intratracheal administration of umbilical cord blood-derived mesenchymal stem cells in a patient with acute respiratory distress syndrome","volume":"29","author":"Hong","year":"2014","journal-title":"J Korean Med Sci"},{"key":"23","first-page":"106","article-title":"Placenta-derived mesenchymal-like cells (PDA-001) as therapy for chronic pulmonary sarcoidosis: a phase 1 study","volume":"32","author":"Lower","year":"2015","journal-title":"Sarcoidosis Vasc Diffuse Lung Dis"},{"key":"24","first-page":"751","article-title":"Investigating the treatment of silicosis with autologous bone marrow-derived mesenchymal stem cells. [Article in Chinese]","volume":"29","author":"Guo","year":"2011","journal-title":"Chin J Ind Hyg Occup Dis"},{"key":"25","first-page":"39","article-title":"Hepatocyte growth factor combined with autologous bone marrow mesenchymal stem cell transplantation for treatment of silicosis. [Article in Chinese]","volume":"29","author":"Guo","year":"2011","journal-title":"Chin J Ind Hyg Occup Dis"},{"key":"26","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1186\/1479-5876-11-171","article-title":"A prospective, non-randomized, no placebo-controlled, phase Ib clinical trial to study the safety of the adipose derived stromal cells-stromal vascular fraction in idiopathic pulmonary fibrosis","volume":"11","author":"Kolios","year":"2013","journal-title":"J Transl Med"},{"key":"27","doi-asserted-by":"publisher","first-page":"10672","DOI":"10.4238\/2015.September.9.7","article-title":"Treatment of silicosis with hepatocyte growth factor-modified autologous bone marrow stromal cells: a non-randomized study with follow-up","volume":"14","author":"Lei","year":"2015","journal-title":"Genet Mol Res"},{"key":"28","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1186\/s12890-015-0061-8","article-title":"Pilot safety study of intrabronchial instillation of bone marrow-derived mononuclear cells in patients with silicosis","volume":"15","author":"Rocco","year":"2015","journal-title":"BMC Pulm Med"},{"key":"29","doi-asserted-by":"publisher","first-page":"1013","DOI":"10.1111\/resp.12343","article-title":"A phase 1b study of placenta-derived mesenchymal stromal cells in patients with idiopathic pulmonary fibrosis","volume":"19","author":"Hopkins","year":"2014","journal-title":"Respirology"},{"key":"30","doi-asserted-by":"publisher","first-page":"30780","DOI":"10.1038\/srep30780","article-title":"Sytematic review and meta-analysis of nasal potential difference in hypoxia-induced lung injury","volume":"6","author":"Ji","year":"2016","journal-title":"Scientific Reports"},{"key":"31","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1016\/S2213-2600(13)70234-0","article-title":"Autologous mesenchymal stromal cell infusion as adjunct treatment in patients with multidrug and extensively drug-resistant tuberculosis: an open-label phase 1 safety trial","volume":"2","author":"Maeurer","year":"2014","journal-title":"Lancet Respir Med"},{"key":"32","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1136\/bmj.327.7414.557","article-title":"Measuring inconsistency in meta-analyses","volume":"327","author":"Altman","year":"2003","journal-title":"BMJ"},{"key":"33","doi-asserted-by":"publisher","first-page":"1199","DOI":"10.5966\/sctm.2015-0021","article-title":"Effects of Mesenchymal Stromal Cells in Two Patients With Severe Acute Respiratory Distress Syndrome","volume":"4","author":"Skog","year":"2015","journal-title":"Stem Cells Transl Med"}],"container-title":["Oncotarget"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.oncotarget.com\/lookup\/doi\/10.18632\/oncotarget.15426","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,10]],"date-time":"2020-05-10T18:34:47Z","timestamp":1589135687000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.oncotarget.com\/lookup\/doi\/10.18632\/oncotarget.15426"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,2,16]]},"references-count":33,"journal-issue":{"issue":"18","published-print":{"date-parts":[[2017,5,2]]}},"alternative-id":["15426","28430622"],"URL":"https:\/\/doi.org\/10.18632\/oncotarget.15426","relation":{},"ISSN":["1949-2553"],"issn-type":[{"value":"1949-2553","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,2,16]]}}}